OXB · 1 day ago
Process Engineer I
OXB is a quality and innovation-led viral vector CDMO focused on enabling life-changing therapies for patients worldwide. They are seeking a Process Engineer to provide operational and equipment support throughout the design and delivery phases, ensuring compliance with safety, regulatory, and quality standards.
BiotechnologyGeneticsTherapeutics
Responsibilities
Of site projects from inception to completion ensuring safety, regulatory and quality compliance
Support equipment and utilities detailed design and commissioning and qualification activities
Support department quality events (e.g. change control, corrective action/preventative action, deviations, etc.)
Support the development and maintenance of equipment drawings (P&IDs, PFDs, etc) and equipment lifecycle (URSs)
Provide support to Facilities/Maintenance team for development of a spare parts program and identify spare parts for incoming equipment
Ensure potential safety hazards are identified/shared and effective actions are rapidly implemented
Must be willing to have a flexible schedule to support 24x7 manufacturing activities
Qualification
Required
BS/MS in Engineering or a related field
Experience in pharmaceutical/biotech manufacturing is a plus
Familiar with FDA and EU regulations and GMP standards is a plus
Prior cGMP cell or gene therapy manufacturing experience is a plus
Willingness to take on other tasks as needed to support site, engineering, and facilities objectives
Benefits
Competitive total reward packages
Wellbeing programs that support your mental and physical health
Career development opportunities to help you grow and thrive
Supportive, inclusive, and collaborative culture
State-of-the-art labs and manufacturing facilities
Company
OXB
OXB (LSE: OXB) is a global quality and innovation-led contract development and manufacturing organisation (CDMO) in cell and gene therapy with a mission to enable its clients to deliver life changing therapies to patients around the world.
Funding
Current Stage
Public CompanyTotal Funding
$217.05MKey Investors
Oaktree Capital ManagementSerum Institute of India Pvt. Ltd.
2025-08-01Post Ipo Debt· $60M
2021-09-22Post Ipo Equity· $68.08M
2019-05-01Post Ipo Equity· $69.83M
Recent News
2025-10-07
2025-10-07
2025-10-07
Company data provided by crunchbase